Werewolf Therapeutics (HOWL) Current Leases (2020 - 2026)
Werewolf Therapeutics (HOWL) posted quarterly Current Leases of $1.6 million for Q1 2026, up 13.6% year-over-year from $1.4 million in Q1 2025, and down 8.4% on a QoQ basis from $1.8 million in Q4 2025.
Werewolf Therapeutics (HOWL) Current Leases (2020 - 2026) Analysis & Trends
Werewolf Therapeutics has reported Current Leases for 7 years, with the latest figure at $1.6 million in Q1 2026.
- Current Leases for Q1 2026 came in at $1.6 million, up 13.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 million (up 13.6% YoY), and the FY2025 annual result was $1.8 million, up 12.46% from the prior year.
- Current Leases fell to $1.6 million in Q1 2026, from $1.8 million in the prior quarter.
- Over five years, Current Leases peaked at $2.1 million in Q1 2023 and troughed at $1.2 million in Q1 2024.
- A 5-year average of $1.6 million and a median of $1.6 million in 2026 frame the typical range for Current Leases.
- The widest annual swing landed in 2022, when Current Leases soared 171.51%; it then tumbled 42.4% in 2024.
- A 5-year view of Current Leases shows it stood at $2.1 million in 2022, then declined by 22.84% to $1.6 million in 2023, then fell by 3.17% to $1.6 million in 2024, then advanced by 12.46% to $1.8 million in 2025, then retreated by 8.4% to $1.6 million in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $1.6 million in Q1 2026, $1.8 million in Q4 2025, and $1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Werewolf Therapeutics | 43.94 Mn | 43.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.60 Mn |
| Dec 31, 2025 | 1.75 Mn |
| Sep 30, 2025 | 1.50 Mn |
| Jun 30, 2025 | 1.45 Mn |
| Mar 31, 2025 | 1.41 Mn |
| Dec 31, 2024 | 1.56 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Jun 30, 2024 | 1.27 Mn |
| Mar 31, 2024 | 1.24 Mn |
| Dec 31, 2023 | 1.61 Mn |
| Sep 30, 2023 | 1.61 Mn |
| Jun 30, 2023 | 1.97 Mn |
| Mar 31, 2023 | 2.15 Mn |
| Dec 31, 2022 | 2.08 Mn |
| Sep 30, 2022 | 2.02 Mn |
| Jun 30, 2022 | 1.87 Mn |
| Mar 31, 2022 | 1.46 Mn |
| Dec 31, 2021 | 1.07 Mn |
| Sep 30, 2021 | 744,000.00 |
| Jun 30, 2021 | 721,000.00 |